Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marsam Pharmaceuticals Inc.

Division of Allergan PLC

Latest From Marsam Pharmaceuticals Inc.

Say Good-bye to the Family Farm

Watson Pharmaceuticals Inc.'s purchase of Schein Pharmaceutical seems to confirm what generics industry experts have known for some time: the industry is consolidating at both the wholesaler and manufacturer levels. The purchase, for $674 million and the assumption of $240 million in debt, is the third time in the past year that a large generics maker has bought a rival. The deal puts Watson, now ranked number four in generics, in a race for first place with Teva Pharmaceutical Industries Inc., which has also been on a buying spree.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Richard A Baron, CFO/VP, Finance
    Marvin Samson, Pres., Treasurer & Director
    E.T. Lillard, VP, Sales
    Edward Moylan, Director, Business Development
    Fakrul Sayeed, PhD, VP, Scientific Affairs
  • Contact Info
  • Marsam Pharmaceuticals Inc.
    Phone: (609) 424-5600
    24 Olney Ave.
    P.O. Box 1022 Cherry Hill, NJ 08034
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register